Advertisement
Research Article| Volume 17, ISSUE 4, P737-752, December 1997

Troponin, Where Do We Go From Here?

  • Allan S. Jaffe
    Correspondence
    Address reprint requests to Allan S. Jaffe, MD, Cardiovascular Division, Department of Medicine, SUNY HSC at Syracuse, 750 E. Adams St., Syracuse, NY 13210
    Affiliations
    From the Cardiovascular Division, State University of New York Health Science Center at Syracuse, Syracuse, New York
    Search for articles by this author
DOI:https://doi.org/10.1016/S0272-2712(18)30195-1
Troponin, Where Do We Go From Here?
Previous ArticleWhy Cardiospecificity is Preeminent in Myocardial Markers of Injury
Next ArticleCumulative Index 1997
      This paper is only available as a PDF. To read, Please Download here.
      There remain some questions concerning the specifity of the troponins, especially cardiac troponin T. Nonetheless, they represent a substantial advance in both speciificity for cardiac injury and improved sensitivity. Thus, it is likely that these markers will lead to the definition of new clinical syndromes by unmasking false positive elevations in MBCK and by identifying elevations indicitave of cardiac abnormalities that could not be detected by any other means. The development of new more sensitive assays should further improve our understanding of disease processes that involve the heart by allowing for more subtle abnormalities to be detected.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Clinics in Laboratory Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Adams III., J.E.
        • Abendschein D.R.
        • Jaffe A.S.
        Biochemical markers of myocardial injury.
        Is MB creatine kinase the choice for the 1990s? Circulation. 1993; 88: 750-763
        • Adams III., J.E.
        • Bodor G.S.
        • Davila-Roman V.G.
        • et al.
        Cardiac troponin I: A marker with high specificity for cardiac injury.
        Circulation. 1993; 88: 101-106
        • Adams III., J.E.
        • Schechtman K.
        • Landt V.
        • et al.
        Comparable detection of acute myocardial infarction by creatine kinase MB isoenzyme and cardiac troponin I.
        Clin Chem. 1994; 40: 1291-1295
        • Adams J.E.
        • Sicard G.
        • Allan B.T.
        • et al.
        Diagnosis of perioperative myocardial infarction with measurement of cardiac troponin I.
        N Engl J Med. 1994; 330: 670-674
        • Anderson P.A.W.
        • Malouf N.N.
        • Oakeley A.E.
        • et al.
        Troponin T isoform expression in humans: A comparison among normal and failing adult heart, fetal heart, and adult and fetal skeletal muscle.
        Circulation. 1991; 69: 1226-1233
        • Antman E.M.
        • Tanasijevic M.J.
        • Thompson B.
        • et al.
        Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes.
        N Engl J Med. 1996; 335: 1342-1349

      7. Apple FS, Falahati A, Paulsen PR, et al: Improved detection of minor ischemic myocardial injury with measurement of cardiac troponin I. Clin Chem, in press

        • Apple F.S.
        • Sharkey S.W.
        • Henry T.D.
        Early serum cardiac troponin I and T concentrations after successful thrombolysis for acute myocardial infarction.
        Clin Chem. 1995; 41: 1197-1198
        • Archer L.T.
        Myocardial dysfunction in endotoxin- and E.
        coli-induced shock: Pathophysiological mechanisms. Circulatory Shock. 1985; 15: 261-280
        • Bhavsar P.
        • Dhoot G.K.
        • Cumming D.V.E.
        • et al.
        Developmental expression of troponin I isoforms in fetal human heart.
        FEBS Lett. 1991; 292: 5-8
        • Bhayana V.
        • Gougoulias T.
        • Cohoe S.
        • Henderson A.R.
        Discordance between results for serum troponin T and troponin I in renal disease.
        Clin Chem. 1995; 41: 312-317
        • Bodor G.S.
        • Porter S.
        • Landt Y.
        • Ladenson J.H.
        The development of monoclonal antibodies and an assay for cardiac troponin-I with preliminary results in suspected myocardial infarction.
        Clin Chem. 1992; 11: 2203-2214
        • Bodor G.S.
        • Porterfield D.
        • Voss E.M.
        • et al.
        Cardiac troponin-I is not expressed in fetal and healthy or diseased adult human skeletal muscle tissue.
        Clin Chem. 1995; 41: 1710-1715
        • Bodor G.S.
        • Porterfield D.
        • Voss E.
        • et al.
        Immunohistochemistry of damaged skeletal muscle. Cardiac troponin T composition in normal and regenerating human skeletal muscle.
        Clin Chem. 1997; 43: 476-584
        • Bohner J.
        • von Pape K.W.
        • Hannes W.
        • Stegmann T.
        False-negative immunoassay results for cardiac troponin I probably due to circulating troponin I autoantibodies [letter].
        Clin Chem. 1996; 42: 2046
        • Cannon 3d, R.O.
        • Camici P.G.
        • Epstein S.E.
        Pathophysiological dilemma of syndrome X.
        Circulation. 1992; 85: 883-892
        • Cohen L.F.
        • Mohabeer A.J.
        • Keffer J.H.
        • Jialal I.
        Troponin I in hypothyroidism.
        Clin Chem. 1996; 42: 1494-1495
        • Galvani M.
        • Ottani F.
        • Ferrini D.
        • et al.
        Prognostic influence of elevated values of cardiac troponin I in patients with unstable angina.
        Circulation. 1997; 95: 2053-2059
        • Guest T.M.
        • Ramanathan A.V.
        • Schechtman K.B.
        • et al.
        Myocardial injury in critically ill medical patients: A surprisingly frequent complication.
        JAMA. 1995; 273: 1945-1949

      20. Hackel DB, Reimer KA, Ideker RE, MILIS Study Group, et al: Comparison of enzymatic and anatomic estimates of myocardial infarct in man. Circulation 70:824-835, 1984

        • Jaffe A.S.
        • Landt Y.
        • Parvin C.A.
        • et al.
        Comparative sensitivity of cardiac troponin I and lactate dehydrogenase isoenzymes for the diagnosing acute myocardial infarction.
        Clin Chem. 1996; 42: 1770-1776
        • Katus H.A.
        • Remppis A.
        • Scheffold T.
        • et al.
        Intracellular compartmentation of cardiac troponin T and its release kinetics in patients with reperfused and nonreperfused myocardial infarction.
        American Journal of Cardiology. 1991; 67: 1360-1367
        • Katus H.A.
        • Remppis A.
        • Neumann F.J.
        • et al.
        Diagnostic efficiency of troponin T measurements in acute myocardial infarction.
        Circulation. 1991; 83: 902-912
        • Katus H.A.
        • Looser S.
        • Hallermayer K.
        • et al.
        Development and in vitro characterization of a new immunoassay of cardiac troponin T.
        Clin Chem. 1992; 38: 386-393
        • Kobayashi S.
        • Tanaka M.
        • Tamura N.
        • et al.
        Serum cardiac troponin T in polymyositis/ dermatomyositis.
        Lancet. 1992; 340: 726
        • Lindahl B.
        • Venge P.
        • Wallentin L.
        Relation between troponin T and the risk of subsequent cardiac events in unstable coronary artery disease.
        The FRISC study group. Circulation. 1996; 93: 1651-1657
        • Lopez-Jimenez F.
        • Goldman L.
        • Sacks D.B.
        • et al.
        Prognostic value of cardiac troponin T after noncardiac surgery: 6-month follow-up data.
        J Am Coll Cardiol. 1997; 29: 1241-1245
        • Mair J.
        • Artner-Dworzak E.
        • Lechleitner P.
        • et al.
        Cardiac troponin T in diagnosis of acute myocardial infarction.
        Clin Chem. 1991; 37: 845-852
        • Mair J.
        • Wagner I.
        • Morass B.
        • et al.
        Cardiac troponin I release correlates with myocardial infarction size.
        Eur J Clin Chem Clin Biochem. 1995; 33: 869-872
        • McLaurin M.D.
        • Apple F.S.
        • Voss E.M.
        • et al.
        Cardiac troponin I, cardiac troponin T, and creatine kinase MB in dialysis patients with ischemic heart disease: Evidence of cardiac troponin T expression in skeletal muscle.
        Clin Chem. 1997; 43: 976-982
        • Missov E.
        • Pau B.
        • Calzolari C.
        Increased circulating levels of cardiac troponin I in anthracycline-treated patients [abstract].
        Circulation. 1996; 94: 4283

      32. Missov E, Calzolari C, Pau B: Cardiac troponin I in severe congestive heart failure. Circulation, in press

        • Mullerbardorff M.
        • Hallermayer K.
        • Schroder A.
        • et al.
        Improved troponin T ELISA specific for cardiac troponin T isoform-assay development and analytical and clinical validation.
        Clin Chem. 1997; 43: 458-466
        • Norris R.M.
        • Johnson R.N.
        • White H.D.
        • Robinson D.R.
        Non-invasive diagnosis of infarct artery patency after acute myocardial infarction by use of serial plasma troponin T concentrations: Importance of measurement of peak levels.
        Heart. 1996; 75: 481-485
        • Omura T.
        • Teragaki M.
        • Takagi M.
        • et al.
        Myocardial infarct size by serum troponin T and myosin light chain 1 concentration.
        Japanese Circulation Journal. 1995; 59: 154-159
        • On L.
        • Reassure P.
        • Corollas J.
        • et al.
        Left ventricular function and rapid release of creatine kinase MB in acute myocardial infarction.
        N Engl J Med. 1983; 309: 1-6
        • Saggin L.
        • Gorza L.
        • Ausoni S.
        • Schiaffino S.
        Troponin I switching in the developing heart.
        J Biol Chem. 1989; 264: 16299-16302
        • Saggin L.
        • Gorza L.
        • Ausoni S.
        • Schiaffino S.
        Cardiac troponin T in developing, regenerating, and denervated rat skeletal muscle.
        Development. 1990; 110: 547-554
        • Schwartz K.
        • de la Bastie D.
        • Bouveret P.
        • et al.
        Skeletal muscle actin mRNA accumulates in hypertrophied adult rat hearts.
        Circ Res. 1986; 59: 551-555
        • Smith S.C.
        • Ladenson J.H.
        • Mason J.W.
        • Jaffe A.S.
        Elevations of cardiac troponin I associated with myocarditis: Experimental and clinical correlates.
        Circulation. 1997; 95: 163-168
        • Smith J.L.
        • Ambos H.D.
        • Gold H.K.
        • et al.
        Enzymatic estimation of myocardial infarct size when early creatine kinase values are not available.
        American Journal of Cardiology. 1983; 51: 1294-1300
        • Toyota N.
        • Shimada Y.
        Differentiation of troponin in cardiac and skeletal muscles in chicken embryos as studied by immunofluorescence microscopy.
        J Cell Biol. 1981; 91: 497-504
        • Vatner S.F.
        • Baig H.
        • Manders W.T.
        • Maroko P.R.
        Effects of coronary artery reperfusion on myocardial infarct size calculated from creatine kinase.
        J Clin Invest. 1978; 61: 1048-1056
        • Wu A.H.
        • Lane P.L.
        Metaanalysis in clinical chemistry: Validation of cardiac troponin T as a marker for ischemic heart diseases.
        Clin Chem. 1995; 41: 1228-1233
        • Wu A.H.
        • Valdes Jr, R.
        • Apple F.S.
        • et al.
        Cardiac troponin-T immunoassay for diagnosis of acute myocardial infarction.
        Clin Chem. 1994; 40: 900-907
        • Wu A.H.
        • Feng Y.J.
        • Herbert K.
        • Schweizer R.
        Cardiac troponins T and I before and after renal transplantation.
        Clin Chem. 1997; 43: 411-412
        • Wynne J.
        • Braunwald E.
        The cardiomyopathies: Toxic, chemical, and physical damage to the heart.
        in: Braunwald E. Heart Disease. ed 4. WB Saunders, Philadelphia1992: 1406

      Article info

      Identification

      DOI: https://doi.org/10.1016/S0272-2712(18)30195-1

      Copyright

      © 1997 Elsevier Inc. Published by Elsevier Inc. All rights reserved.

      ScienceDirect

      Access this article on ScienceDirect
      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties. The content on this site is intended for healthcare professionals.


      RELX